Brailer Leads New Venture Capital Firm


Author: Neil Versel
Former national health-IT coordinator David Brailer has surfaced as the head of a new private equity firm, backed by a mammoth commitment of cash from America’s largest pension fund.

Brailer late Monday announced the creation of Health Evolution Partners, a San Francisco-based group he is chairman of. While he is not ready to go public with the names of his other partners, he said that the California Public Employees’ Retirement System, or CalPERS, has committed as much as $700 million to the effort.

At press time, CalPERS, with holdings valued at close to $250 billion, was planning a Tuesday press conference to discuss its investment.

“This is a very capital-intensive business,” Brailer says, in explaining the need for such a large pool of cash. While he reports that other, unspecified pension funds and university endowments have expressed interest in participating as well, Brailer says, “I’m not going to let any people come into the fund for up to a year.”

Health Evolution Partners has not announced any investments of its own, but Brailer says he is targeting September to talk about specifics of the company’s strategy, introduce other senior staff, and perhaps disclose an investment or two. A fact sheet on the company’s Web site indicates that Brailer and his backers are looking for investments in the areas of consumer empowerment, healthcare efficiency and quality improvement, information services, and personalized medicine.

The former national health-IT chief, who left government service in May 2006, says that his new firm is more than a venture-capital operation. “We’re not focused on the new ventures exclusively.”

Brailer, who has a doctorate in economics in addition to his medical degree, says he will devote the bulk of his time to this investment venture for the next several years, but plans to continue serving as vice chairman of the American Health Information Community, a public-private advisory board to the U.S. Department of Health and Human Services.

Want to read more expert articles like this? Send an email to:
subscribe-digital_healthcare_productivity@newsletters.digitalhcp.com.

Click here to log in.

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

White Papers & Special Reports

Software Helps Doping Control Lab Streamline Results Management
Sponsored by Waters
The Karolinska University Hospital’s Doping Control Lab tests thousands of samples annually for stimulants, diuretics, and other masking agents. Increased regulatory pressure and new technologies increased the number of samples analyzed creating data management challenges. Waters® NuGenesis® Scientific Data Management System and TargetLynx™ Application Manager software were used to reduce the time required to calculate, review and search results.


Managed Innovation, Assured Compliance
Sponsored by SAS
Discovery organizations are identifying a lot of promising compounds, but clinical research processes haven't kept pace with timely testing of all those potential therapies. This white paper describes how SAS® Drug Development supports true innovation across the clinical trial process.

In this white paper you will learn how to:

  • Assemble data to foster better collaboration
  • Get up-to-date information during clinical trials
  • Make informed decisions earlier in the trial process


Addressing Life Sciences Constantly Growing Data Challenges Research Environments
Sponsored by BlueArc
The continued explosion of raw experimental data, the increased use of video, the growing adoption of new data retention practices, and the move to high throughput computational workflows are all placing new demands on the way life sciences organizations store and manage their data.

Download this white paper to learn about:

  • Factors driving the data explosion in the life sciences
  • New data management issues that must be addressed
  • HPC trends that are placing new demands on storage
  • Storage solution attributes that address performance, manageability, and energy efficiency.


Life Science Webcasts & Podcasts

Medidata Solutions

Rising Clinical Trial Delays and Costs - Addressing the Cause, Not the Symptoms

Protocol complexity is taking a toll on clinical study speed and efficiency: increasingly complicated and ambitious protocols are not only burdening sites and study volunteers but are also prolonging trials and increasing expenses. In response, sponsors have turned to global study placement, restructured site relationships and new site management practices, but the problem remains.

This podcast will discuss:

  • Why these responses address only the symptoms, not the underlying cause, of rising clinical trial delays and costs.
  • Results of a recent joint Tufts University / Medidata Solutions study.
  • New metrics benchmarking protocol design trends.
  • Systematic protocol design improvements and why they are essential to clinical trial performance excellence.

Speakers: Ken Getz, Senior Research Fellow at the Tufts Center for the Study of Drug Development, and Ed Seguine, General Manager, Trial Planning Solutions at Medidata.

Download Now



More Podcasts

Job Openings

Director, Center For Information Technology (CIT) - National Institutes of Health (NIH), Department of Health and Human Service
Located in Bethesda, MD. This position requires:
• High-level vision, leadership, management, and modernization of CIT programs and services.
• Strategic direction and policy development for CIT long-term operations and objectives.
• Serve as a key IT advisor to the NIH Chief Information Officer.
A TOP SECRET security clearance will be required. More job detail is found at: http://www.jobs.nih.gov under the Executive Jobs section.Or contact Ms.Winnie Garner at [email protected]. Applications must be received ELECTRONICALLY by (11:59 p.m.), December 17, 2008. DHHS and NIH are Equal Opportunity Employers

Bioinformatics Manager- Lilly Singapore Centre for Drug Discovery
For more information click here

Related Resources & Products

GPCRs: Dawn of a New Era?
The Expanding Impact of New Animal Models in Drug Safety
Novel Approaches to Lead Optimization
Novel Approaches to Lead Optimization



For reprints and/or copyright permission, please contact The YGS Group, 1808 Colonial Village Lane, Lancaster, PA;

(717) 399-1900 ext. 125, or via email to [email protected].